載入...
Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates
Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...
Na minha lista:
| 發表在: | Front Pediatr |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078308/ https://ncbi.nlm.nih.gov/pubmed/32219085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2020.00076 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|